Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone
- PMID: 7873463
Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone
Abstract
Bisphosphonates influence the morphology and mechanical properties of bones in growing rats, but their effects on fracture repair are not well documented. This study tests the hypothesis that bisphosphonates will modulate the remodelling phase of fracture repair, influencing the mechanical properties of healing bone. The effects of a bisphosphonate (pamidronate, Aredia) on the healing of a 3 mm osteotomy gap in the mid-diaphysis of the tibia, under rigid unilateral external fixation, were evaluated using 2 groups of 6 skeletally mature sheep. The repair process was evaluated weekly for 12 weeks using conventional radiographs, dual photon absorptiometry, and fracture stiffness measurements. The animals were then killed and the torsional stiffness and strength of the tibiae measured. More prolific callus formation, with an associated rise in the rate of bone mineral content, was observed in the treated group. There were no differences in in vivo fracture stiffness or postmortem torsional stiffness between the 2 groups, but torsional strength was greater in the treated group. Callus remodelling was reduced but not arrested in the treated group. Bisphosphonates act to reduce callus remodelling, leading to an increased amount of bridging callus and therefore strength. This study indicates that pamidronate has no adverse effects on the restoration of the mechanical integrity of a long bone after fracture.
Similar articles
-
A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair.J Orthop Res. 2005 Sep;23(5):1029-34. doi: 10.1016/j.orthres.2005.03.004. Epub 2005 Apr 19. J Orthop Res. 2005. PMID: 16140188
-
Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.J Bone Miner Res. 1998 Sep;13(9):1483-90. doi: 10.1359/jbmr.1998.13.9.1483. J Bone Miner Res. 1998. PMID: 9738522
-
Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.Bone. 2008 Oct;43(4):653-62. doi: 10.1016/j.bone.2008.05.019. Epub 2008 Jun 3. Bone. 2008. PMID: 18582604
-
Systemic administration of pharmacological agents and bone repair: what can we expect.Injury. 2011 Jun;42(6):605-8. doi: 10.1016/j.injury.2011.03.061. Epub 2011 Apr 19. Injury. 2011. PMID: 21507402 Review.
-
[Bone fracture and the healing mechanisms. The effects of anti-resorptive agents on fracture healing].Clin Calcium. 2009 May;19(5):673-9. Clin Calcium. 2009. PMID: 19398835 Review. Japanese.
Cited by
-
High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model.Yonsei Med J. 2007 Aug 31;48(4):653-8. doi: 10.3349/ymj.2007.48.4.653. Yonsei Med J. 2007. PMID: 17722238 Free PMC article.
-
The effect of zoledronate during bone healing.J Orthop Traumatol. 2010 Mar;11(1):7-12. doi: 10.1007/s10195-010-0083-1. Epub 2010 Feb 19. J Orthop Traumatol. 2010. PMID: 20169393 Free PMC article.
-
Association between timing of zoledronic acid infusion and hip fracture healing.Osteoporos Int. 2011 Aug;22(8):2329-36. doi: 10.1007/s00198-010-1473-1. Epub 2010 Dec 9. Osteoporos Int. 2011. PMID: 21153021 Clinical Trial.
-
Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.Osteoporos Int. 2016 Jan;27(1):211-8. doi: 10.1007/s00198-015-3266-z. Epub 2015 Aug 21. Osteoporos Int. 2016. PMID: 26294293 Clinical Trial.
-
Kummell's Disease is Becoming Increasingly Important in an Aging Society: A Review.Korean J Neurotrauma. 2023 Mar 22;19(1):32-41. doi: 10.13004/kjnt.2023.19.e13. eCollection 2023 Mar. Korean J Neurotrauma. 2023. PMID: 37051029 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous